All Type of News
Nexavar improves survival in liver cancer
Nexavar (sorafenib) tablets significantly improved overall survival by 47.3 percent in patients in the Asia-Pacific region with advanced hepatocellular carcinoma (HCC), according to Bayer HealthCare.
In a local sym...
Doctor to hold debate forum over new prescription plan
The Korea Medical Association (KMA) plans to hold its open forum over the government’s new prescription plan on June 28.
Under the new plan, medical doctors will have to make prescriptions listing only chemical ing...
Green Cross wins NGSP Level I
Green Cross Reference Lab. said on June 12 it has acquired Level I certification from the National Glycohemoglobin Standardization Program (NGSP) for the first time in Korea.
The NGSP offers three types of certific...
Ilyang to market new analgesics 'EVE' seriesIlyang says it has begun to distribute SS Pharmaceutical’s over-the-counter analgesics 'EVE' series through pharmacies nationwide from June 10.
Eve-Quick tablets, which conta...
|
Painting insecticide gaining popularityA new type of painting insecticide, Matul-ki (chlorpyrifos), draws keen attention from pharmacists.
Chlorpyrifos is a broad spectrum insecticide, a chemical used to kill a wi...
|
Doctor to become HIRA headChang Jong-ho, former chairman of the Korean Federation of Medical Foundation, will like become a new president of the Health Insurance Review & Assessment Service.
The Minis...
|
Enteric-coated formulation of Myfortic reduces GI disorders
In a new multicenter study, kidney transplant physicians reported a significant reduction in the incidence and symptom severity of gastrointestinal (GI) complications after conversion from MMF to enteric-coated Myfort...
Daewha Pharm wins Korean patent for amodipine
Daewha Pharm announced in its regulatory filing on June 11 that it acquired a Korea patent for manufacturing film-coated granules containing amodipine or S-amlodipine salts and excipients.
S-amlodipine salts are sa...
Kang named head of OTC marketing department
Daewoong Pharm says that Kang Min-goo as been named as its managing director of OTC marketing department.
Kang is a classic healthcare man, having worked for Johnson and Johnson Korea for 15 years.
The company ...
KYG launches DNA-filter smoking cessation products
KYG Company says it has marketed a variety of DNA-filter smoking prevention products “NosmoQ” from May.
DNA cigarette filter can effectively remove various critical cancer-causing substances such as dioxins and ben...
